Related Experiment Video
Updated: Apr 18, 2026

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
Published on: January 3, 2020
Morin hydrate attenuates Staphylococcus aureus virulence by inhibiting the self-assembly of α-hemolysin
1Key Laboratory of Zoonosis, Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, Jilin University, Changchun, China.
Aims:
To investigate the mechanism by which morin hydrate inhibits the haemolytic activity of α-hemolysin (Hla), a channel-forming toxin that is important for the pathogenesis of disease in experimental animals, and its therapeutic effect against Staphylococcus aureus pneumonia in a mouse model.
Methods And Results:
The results from the in vitro (haemolysis, western blot and cytotoxicity assays) and in vivo (mouse model of intranasal lung infection) experiments indicated that morin hydrate, a natural compound with little anti-Staph. aureus activity, could effectively antagonize the cytolytic activity of Hla, alleviate human lung cell injury, and protect against mortality of Staph. aureus pneumonia in a mouse model of infection. Molecular dynamics simulations, free energy calculations and mutagenesis assays were further employed to determine the catalytic mechanism of inhibition, which indicated that a direct binding of morin to the 'Stem' domain of Hla (residues I107 and T109) and the concomitant change in conformation led to the inhibition of the self-assembly of the heptameric transmembrane pore, thus inhibiting the biological activity of Hla for cell lysis.
Conclusions:
Morin inhibited Staph. aureus virulence via inhibiting the haemolytic activity of α-hemolysin.
Significance And Impact Of The Study:
These findings suggested that morin is a promising candidate for the development of anti-virulence therapeutic agents for the treatment of Staph. aureus infections.
Insights
Morin hydrate effectively inhibits alpha-hemolysin, a toxin from Staphylococcus aureus, reducing pneumonia severity in mice. This natural compound shows promise as an anti-virulence therapy for Staph. aureus infections.
Area of Science:
- Microbiology and Immunology
- Pharmacology
- Biochemistry
Background:
- Staphylococcus aureus is a significant human pathogen, with alpha-hemolysin (Hla) being a key virulence factor responsible for cytolytic activity and disease pathogenesis.
- Existing treatments for S. aureus infections face challenges due to rising antibiotic resistance, necessitating the exploration of novel therapeutic strategies targeting virulence factors.
Purpose of the Study:
- To elucidate the mechanism by which morin hydrate inhibits the hemolytic activity of alpha-hemolysin (Hla).
- To evaluate the therapeutic potential of morin hydrate against Staphylococcus aureus pneumonia in a preclinical mouse model.
Main Methods:
- In vitro assays including hemolysis, western blot, and cytotoxicity tests were performed.
- A mouse model of intranasal lung infection was utilized for in vivo efficacy assessment.
- Molecular dynamics simulations, free energy calculations, and mutagenesis assays were employed to determine the inhibition mechanism.
Main Results:
- Morin hydrate demonstrated significant antagonism of Hla's cytolytic activity and alleviated human lung cell injury.
- In vivo studies showed morin hydrate protected against mortality in a mouse model of Staphylococcus aureus pneumonia.
- Molecular simulations revealed morin binds to the 'Stem' domain of Hla, inhibiting heptameric pore formation and thus Hla's biological activity.
Conclusions:
- Morin hydrate effectively inhibits Staphylococcus aureus virulence by targeting the hemolytic activity of alpha-hemolysin.
- Morin hydrate represents a promising candidate for developing anti-virulence therapeutics against Staphylococcus aureus infections.
More Related Videos
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Gene Regulation in Microbial Communities: Quorum Sensing
Mechanism of Antibiotic Resistance in MRSA
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Bacterial Protein Synthesis

